New Products

NEW YORK — Nicole by OPI has launched for the holiday season two new gift sets featuring nail lacquers inspired by actress and singer Selena Gomez.

NEW YORK — Coty and Prada Group have formed an exclusive partnership to create, develop and distribute a signature line of fragrances under the Miu Miu name — marking Miu Miu's first entry into the world of prestige fragrances.

RESEARCH TRIANGLE PARK, N.C. — A once-daily inhaler for chronic obstructive pulmonary disease has become available, the makers of the inhaler said Wednesday.

GlaxoSmithKline and Theravance announced the availability of Breo Ellipta (fluticasone furoate; vilanterol), for long-term maintenance treatment of airflow obstruction in patients with COPD, a term that encompasses chronic bronchitis and emphysema. The drug is not meant for treating acute bronchospasm or asthma, the companies said.

BOCA RATON, Fla. — STUF Men’s Defense, a skin care line just for guys, has announced that it is now being sold on Amazon.com.

Commissioned by 11-time Olympic medalist Mark Spitz, STUF Men’s Defense is made from naturally produced ingredients, including combinations of herbs, antioxidants and vitamins, and the products do not contain any animal byproducts, mineral oils, parabens, colorants or phthalates.

ARMONK, N.Y. — The University of Arizona College of Pharmacy is switching from a MacOS-based platform to an IBM system running Linux to manage growth of big data.

IBM said Wednesday that the Tucson, Ariz., college was using an IBM zEnterprise mainframe running the IBM DB2 database software on Linux to analyze and process 3 million medical claims per week. A business partner of IBM, Sirius Computer Solutions, helped the college move to the new system, which reduces the time it takes to process medical claims by 60%.

DEERFIELD, Ill. — The Food and Drug Administration has approved a drug made by Lundbeck for treating a form of epilepsy in children, the drug maker said.

Lundbeck announced the approval of Sabril (vigabatrin) as an add-on therapy for refractory complex partial seizures in children ages 10 years and older who have not responded adequately to other treatments, as long as the benefit of treatment outweighs the risk of vision loss. The drug was already approved for treating the same condition in adults in 2009.

BOCA RATON, Fla. — MelanSol, an all-natural sunscreen brand, has announced that it is working to expand the availability of its products across the United States.

DUBLIN — Actavis hopes to become the first company to market a generic version of a drug used to treat acne in adolescents and adults, the company said.

The drug maker announced that it had filed a regulatory approval application with the Food and Drug Administration for a generic version of Acanya (clindamycin phosphate; benzoyl peroxide) gel in the 1.2%/2.5% strength. Acanya is made by Valeant Pharmaceuticals International and Dow Pharmaceutical Sciences and is used to treat acne vulgaris in patients aged 12 and older.